VR Solution Partner - Smileyscope

Needlephobic behavior and anxiety effects 75% of children under the age of 18 resulting in healthcare avoidant behavior, stress on patients and HCPs, and billions in cost to the healthcare system.

Smileyscope's VR therapeutic addresses this common problem through a patented neuromodulation process that reduces pain signals to the brain and reframes negative real-world stimuli by replacing it with positive VR stimuli at key points in a procedure. The two largest VR trials to date show that Smileyscope reduces pain and anxiety associated with these procedures by 60% and 40%, respectively.